Telavancin

DRUG13 trials

Conditions

AbscessBacteremiaBacterial PneumoniaBurnsCellulitisEnd Stage Renal DiseaseEnd-Stage Renal DiseaseGram-Positive Bacterial Infections

Phase 1

A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin

CompletedNCT01238796

Cumberland PharmaceuticalsEnd Stage Renal Disease, Kidney Diseases

Start: 2010-12-31End: 2011-02-28Updated: 2019-01-15

Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)

TerminatedNCT02013141

Cumberland PharmaceuticalsGram-Positive Bacterial Infections

Start: 2014-12-31End: 2021-03-31Updated: 2024-06-24

Pharmacokinetics of Telavancin in Normal and Obese Subjects

CompletedNCT02753855

University of Illinois at ChicagoHealthy

Start: 2016-04-30End: 2016-10-31Updated: 2016-11-02

Phase 2

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

CompletedNCT00061633

Cumberland PharmaceuticalsAbscess, Burns, Cellulitis +3

Start: 2003-06-30End: 2004-01-31Updated: 2019-01-16

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

CompletedNCT00062647

Cumberland PharmaceuticalsGram-Positive Bacterial Infections

Start: 2003-08-31End: 2006-08-31Updated: 2019-01-16

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

CompletedNCT00077675

Cumberland PharmaceuticalsInfections, Gram-positive Bacterial

Start: 2004-02-29End: 2004-09-30Updated: 2019-01-16

Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients

CompletedNCT01321879

M.D. Anderson Cancer CenterBacteremia, Infection

Start: 2011-03-31End: 2016-12-31Updated: 2019-12-27

Phase 3

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

CompletedNCT00091819

Cumberland PharmaceuticalsStaphylococcal Skin Infection

Start: 2005-01-31End: 2006-06-30Updated: 2019-01-16

Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus

CompletedNCT00107952

Cumberland PharmaceuticalsBacterial Pneumonia

Start: 2005-02-28End: 2007-07-31Updated: 2019-01-16

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

CompletedNCT00107978

Cumberland PharmaceuticalsStaphylococcal Skin Infection

Start: 2005-02-28End: 2006-05-31Updated: 2019-01-16

Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus

CompletedNCT00124020

Cumberland PharmaceuticalsBacterial Pneumonia

Start: 2005-01-31End: 2007-05-31Updated: 2019-01-16

A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

TerminatedNCT02208063

Cumberland PharmaceuticalsBacteremia

Start: 2014-12-31End: 2018-04-12Updated: 2020-02-17

Phase 4

Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5

CompletedNCT02392208

University of MichiganEnd-Stage Renal Disease, Stage 5 Chronic Kidney Disease

Start: 2015-07-31End: 2016-03-31Updated: 2017-04-04

Journal of Antimicrobial Chemotherapy2021-09-173 citations

Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.

2018-02-157 citations

Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects

Antimicrobial Agents and Chemotherapy2018-01-0912 citations

Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates.

2016-10-073 citations

Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer

Antimicrobial Agents and Chemotherapy2015-10-2010 citations

Telavancin: the long and winding road from discovery to food and drug administration approvals and future directions.

2015-09-0120 citations

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.

2014-05-2354 citations

Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies.

2014-04-0434 citations

Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections.

2012-03-1317 citations